Supporting Cancer Care During COVID-19

Read more

The Relentless Pursuit of Better CareOptionsInsightsScience

We never give up. We strive to do more for cancer patients - through richer science, deeper insights, and stronger partnerships - providing better cancer care today, and fueling better cancer care tomorrow.


Foundation Medicine, a molecular insights company, is connecting physicians and their patients to the latest cancer treatment approaches and making precision medicine a reality for thousands.

Better Care Today


Genomic Testing

Comprehensive Genomic Profiling

Our portfolio of genomic tests is the leading platform for comprehensive genomic profiling. We analyze more than 300 genes across the four main classes of genomic alterations to help understand the genomic makeup of a patient's tumor.


Molecular Insights

Valuable Insights, Actionable Options

We help match each patient’s unique genomic profile to known targeted therapies, immunotherapies and clinical trials and offer decision support services, financial assistance, and technology solutions to help streamline patient care.

Patient Story

Dealing with cancer is not just dealing with the cancer. It’s treating the whole person.


Christine Bray, ovarian cancer survivor, shares her journey to remission after obtaining a Foundation Medicine comprehensive genomic profiling test.

Christine Bray

Better Care Tomorrow


More Than Numbers

Insights, Not Just Information

Our unique knowledgebase, FoundationCore®, is one of the world's largest cancer genomic databases, with more than 400,000 anonymized patient records, designed to help researchers and biopharma companies advance precision medicine, develop new therapies, and design better trials.


Supporting Drug Development

The Preferred Partner to BioPharma

We partner with drug developers throughout each stage of drug research and development, from target discovery to commercial launch. Today, we are working with more than 50 biopharma partners to accelerate new biomarker-driven treatments.

Advancing Cancer Care

The Power Of Partnership In Precision Medicine


FoundationOne CDx was recently approved to identify mutations that lead to MET exon 14 skipping in advanced non-small cell lung cancer (NSCLC) and match patients with a new targeted therapy, which was approved in parallel. Learn more on our blog about how this approval demonstrates the power of cancer precision medicine in action and the role that comprehensive genomic profiling plays.

Garrett Frampton, PhD, Sr. Director, Cancer Genomics

Better Care Together


Collective Advances

The Power of Collaboration

By sharing our genomic data, we empower researchers on the front lines to generate new connections and insights. Today, we proudly participate in a number of sharing initiatives to accelerate research efforts.


Transforming Cancer Care

Cultivating an Ecosystem of Partners

Every insight we gain towards better cancer care is multiplied by a hyper-connected network of physicians, biopharma, researchers, patient advocacy organizations and world-leading medical centers. Together, we are transforming cancer care.

We are deeply committed to the health and care of patients, and we acknowledge the extraordinary impact COVID-19 continues to have on patients with cancer, and the community at large. We have taken steps to keep our labs open and operational to continue to provide access to our portfolio of tests and services.

Read the Article

Join Us in the Pursuit of Better

Find out more about genomic testing, learn more about us, or read the latest updates from our blog.